๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

ID2: CHRONIC HEPATITIS C: COST-EFFECTIVENESS OF INTERFERON AND RIBAVIRIN

โœ Scribed by ME Singer; K Shermock; ZM Younossi


Book ID
118613468
Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
54 KB
Volume
2
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Cost-effectiveness of interferon alfa 2b
โœ W. Ray Kim; John J. Poterucha ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 34 KB ๐Ÿ‘ 2 views

In their paper in the November issue of HEPATOLOGY, Younossi et al. 1 may have overestimated the cost effectiveness of interferon-ribavirin treatment. This mainly stems from their failure to take into account the fact that patients who achieve sustained response are not homogenous with respect to th

Cost effectiveness of interferon ฮฑ2b com
โœ Zobair M. Younossi; Mendel E. Singer; John G. McHutchison; Kenneth M. Shermock ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 132 KB ๐Ÿ‘ 1 views

## Treatment of chronic hepatitis C with Interferon (IFN) โฃ2b monotherapy results in 10% to 15% sustained virological response (SVR). Combining IFN with ribavirin increases this response. In this analysis, using the Markov model, 6 treatment strategies for chronic hepatitis C (previously untreated